Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
SNY
VRTX
Add up to 3 more stocks
SNY
Sanofi
-0.31%
$44.33-0.14Delayed quote: Sep 3, 2026, 4:00 PM EDT
Market Cap
$106.45B
52W Range
$40.89 - $52.68
VRTX
Vertex Pharmaceuticals Incorporated
+0.22%
$557.96+1.21Delayed quote: Sep 3, 2026, 4:00 PM EDT
Market Cap
$141.61B
52W Range
$374.17 - $560.25
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 79.88 | 32.41 |
| Forward P/E | N/A | 29.70 |
| P/B Ratio | 1.35 | 7.03 |
| P/S Ratio | 1.87 | 11.28 |
| P/FCF Ratio | 7.79 | 37.50 |
| EV/EBITDA | 10.10 | 27.14 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 73.0% | 86.0% |
| Operating Margin | 14.7% | 38.6% |
| Net Margin | 8.1% | 34.9% |
| ROE | 5.8% | 21.8% |
| ROA | 3.1% | 16.1% |
| ROIC | 5.4% | 17.3% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 0.99 | 3.19 |
| Quick Ratio | 0.23 | 2.74 |
| Debt/Equity | 0.34 | 0.10 |
| Interest Coverage | 15.33 | 357.95 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | 5.4% | N/A |
| Payout Ratio | 64.4% | N/A |
| Yrs of Dividend Growth | 3 | 0 |
N/A includes metrics that are structurally not meaningful for a company's sector (e.g. EV multiples, free-cash-flow ratios, and working-capital ratios for banks and insurers). Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.